FOXM1 protein identified as key driver in immunotherapy resistance, unlocking new therapeutic avenues For years, scientists have found the overexpression of a specific protein called FOXM1 in a wide range of cancers, including ovarian, breast and pediatric cancers. A recent study by scientists at The University of Texas Health Science Center at San Antonio […]
Share This Story
A cancer diagnosis is always devastating and is especially overwhelming when the patient is a child. This is why the CURE Childhood Cancer Foundation is on a mission to advance research that will bring an end to childhood cancers. Recently, Raushan Kurmasheva, PhD, assistant professor at the Greehey Children’s Cancer Research Institute and Department of […]
Share This Story
Every dental patient is different and even small improvements in dental materials can have a big impact on their care. But selecting the best products to ensure long-term, reliable results can involve time-intensive trial and error. A collaboration between The University of Texas Health Science Center at San Antonio (UT Health San Antonio) and The […]
Share This Story
The William and Ella Owens Medical Research Foundation recently awarded $1.5 million to The University of Texas Health Science Center at San Antonio (UT Health San Antonio) for research projects that address pancreatic cancer, Alzheimer’s disease and childhood cancers. This year, the foundation will fund $250,000 each to six research projects from UT Health […]
Share This Story
The University of Texas Health Science Center at San Antonio (UT Health San Antonio) has been awarded $1.25 million by the Max and Minnie Tomerlin Voelcker Fund to support research projects being conducted by the institution’s early career investigators. Voelcker Fund Young Investigator Awards The Voelcker Fund Young Investigator Award will fund each recipient’s […]
Share This Story
In a multi-institutional study published in Science Direct, researchers revealed that testing urine-based tumor DNA (utDNA) can help predict which bladder cancer patients are at higher risk for recurrence after treatment. This study analyzed utDNA from patients in the SWOG S1605 trial, who were treated with atezolizumab, an immunotherapy drug. Researchers used the UroAmp test to examine […]
Share This Story
Scientists at The University of Texas Health Science Center at San Antonio (UT Health San Antonio) have made one of the most important discoveries to date in the study and treatment of BRCA1-deficient cancers and drug resistance. Approximately one in 300 Americans have a pathogenic mutation in the BRCA1 or BRCA2 gene, placing them at an […]
Share This Story
This story was first published in the June 2025 issue of Bexar County Medical Society’s San Antonio Medicine magazine. For Jeremy Tanner, MD, behavioral neurologist and assistant professor of neurology at The University of Texas Health Science Center at San Antonio (UT Health San Antonio) and Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases, […]
Share This Story
More than 600 teams from 58 countries around the world entered the XPRIZE Healthspan competition. That number has now been whittled down to 100 semifinalists and 40 top award-winning milestone teams, including a team at The University of Texas Health Science Center at San Antonio (UT Health San Antonio) Sam and Ann Barshop Institute […]
Share This Story
The University of Texas Health Science Center at San Antonio (UT Health San Antonio) received $3,395,970 in new academic research and prevention awards as part of the latest $98 million funding round announced on May 21 by the Cancer Research Prevention Institute of Texas (CPRIT). The state agency, which focuses on funding evidence-based cancer […]
Share This Story